NEW YORK (360Dx) – Hørsholm, Denmark-based ExpreS2ion Biotech Holding said today that it its subsidiary ExpreS2ion Biotechnologies has entered a collaboration that gives Institut VirionSerion in Würzburg, Germany access to evaluate new in vitro diagnostic candidates produced using the ExpreS2 platform.

The collaboration also grants Virion commercial rights to promote, sell, and distribute protein antigens produced using the same platform.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.